Last reviewed · How we verify
FRUNEVETMAB
At a glance
| Generic name | FRUNEVETMAB |
|---|---|
| Modality | Monoclonal antibody |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
- Vomiting
- Injection site pain
- Diarrhea
- Abnormal behavior and behavioral disorders
- Renal insufficiency
- Anorexia
- Lethargy
- Dermatitis
- Alopecia
- Dehydration
Serious adverse events
- Anti-drug antibodies (ADAs) with treatment failure
- Renal insufficiency
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FRUNEVETMAB CI brief — competitive landscape report
- FRUNEVETMAB updates RSS · CI watch RSS